{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:22:52Z","timestamp":1790630572197,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T00:00:00Z","timestamp":1499731200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s11255-017-1656-1","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T23:20:06Z","timestamp":1499728806000},"page":"1823-1833","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Position-related renal perfusion disturbances as a possible underestimated mechanism in patients with resistant hypertension: a case vignette"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3308-5923","authenticated-orcid":false,"given":"Jan","family":"Schiefer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Amthauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Genseke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Chatzikyrkou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,11]]},"reference":[{"issue":"25","key":"1656_CR1","doi-asserted-by":"publisher","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","volume":"117","author":"DA Calhoun","year":"2008","unstructured":"Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM (2008) Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 117(25):e510\u2013e526. doi: 10.1161\/CIRCULATIONAHA.108.189141","journal-title":"Circulation"},{"issue":"12","key":"1656_CR2","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/s0895-7061(01)02193-8","volume":"14","author":"MA Brown","year":"2001","unstructured":"Brown MA, Buddle ML, Martin A (2001) Is resistant hypertension really resistant? Am J Hypertens 14(12):1263\u20131269. doi: 10.1016\/s0895-7061(01)02193-8","journal-title":"Am J Hypertens"},{"issue":"1","key":"1656_CR3","first-page":"41","volume":"160","author":"JJ Caro","year":"1999","unstructured":"Caro JJ, Speckman JL, Salas M, Raggio G, Jackson JD (1999) Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. Can Med Assoc J 160(1):41\u201346","journal-title":"Can Med Assoc J"},{"issue":"6","key":"1656_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jash.2016.03.186","volume":"10","author":"H Bhatt","year":"2016","unstructured":"Bhatt H, Siddiqui M, Judd E, Oparil S, Calhoun D (2016) Prevalence of pseudoresistant hypertension due to inaccurate blood pressure measurement. J Am Soc Hypertens 10(6):493\u2013499. doi: 10.1016\/j.jash.2016.03.186","journal-title":"J Am Soc Hypertens"},{"issue":"4","key":"1656_CR5","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1161\/CIR.0b013e3182009701","volume":"123","author":"VL Roger","year":"2011","unstructured":"Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J, on behalf of the American Heart Association Statistics C, Stroke Statistics S (2011) Heart disease and stroke statistics\u20142011 update: a report from the American Heart Association. Circulation 123(4):e18\u2013e209. doi: 10.1161\/CIR.0b013e3182009701","journal-title":"Circulation"},{"issue":"1","key":"1656_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0147-0272(79)80023-9","volume":"4","author":"CV Ram","year":"1979","unstructured":"Ram CV, Engelman K (1979) Pheochromocytoma\u2014recognition and management. Curr Probl Cardiol 4(1):1\u201337","journal-title":"Curr Probl Cardiol"},{"issue":"3","key":"1656_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1161\/01.hyp.0000158259.68614.40","volume":"45","author":"C Shibao","year":"2005","unstructured":"Shibao C, Arzubiaga C, Roberts LJ, Raj S, Black B, Harris P, Biaggioni I (2005) Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders. Hypertension 45(3):385\u2013390. doi: 10.1161\/01.hyp.0000158259.68614.40","journal-title":"Hypertension"},{"issue":"2","key":"1656_CR8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/01.HYP.7.2.196","volume":"7","author":"DH Streeten","year":"1985","unstructured":"Streeten DH, Auchincloss JH Jr, Anderson GH Jr, Richardson RL, Thomas FD, Miller JW (1985) Orthostatic hypertension. Pathogenetic studies. Hypertension 7(2):196\u2013203","journal-title":"Hypertension"},{"issue":"3","key":"1656_CR9","first-page":"326","volume":"111","author":"DH Streeten","year":"1988","unstructured":"Streeten DH, Anderson GH Jr, Richardson R, Thomas FD (1988) Abnormal orthostatic changes in blood pressure and heart rate in subjects with intact sympathetic nervous function: evidence for excessive venous pooling. J Lab Clin Med 111(3):326\u2013335","journal-title":"J Lab Clin Med"},{"issue":"1","key":"1656_CR10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/01.HYP.31.1.77","volume":"31","author":"K Kario","year":"1998","unstructured":"Kario K, Eguchi K, Nakagawa Y, Motai K, Shimada K (1998) Relationship between extreme dippers and orthostatic hypertension in elderly hypertensive patients. Hypertension 31(1):77\u201382","journal-title":"Hypertension"},{"issue":"5","key":"1656_CR11","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0022-5347(01)64093-X","volume":"158","author":"P Fornara","year":"1997","unstructured":"Fornara P, Doehn C, Jocham D (1997) Laparoscopic nephropexy: 3-year experience. J Urol 158(5):1679\u20131683","journal-title":"J Urol"},{"issue":"4\u20135","key":"1656_CR12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000277571","volume":"12","author":"PA Narath","year":"1961","unstructured":"Narath PA (1961) Nephroptosis. Urol Int 12(4\u20135):164\u2013190","journal-title":"Urol Int"},{"issue":"2","key":"1656_CR13","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0022-5347(05)65961-7","volume":"166","author":"E Plas","year":"2001","unstructured":"Plas E, Daha K, Riedl CR, Hubner WA, Pfluger H (2001) Long-term followup after laparoscopic nephropexy for symptomatic nephroptosis. J Urol 166(2):449\u2013452. doi: 10.1016\/S0022-5347(05)65961-7","journal-title":"J Urol"},{"issue":"3","key":"1656_CR14","first-page":"171","volume":"5","author":"J Prandota","year":"1984","unstructured":"Prandota J, Ostrowska-Skora J (1984) Normal limits for renal mobility in children. Int J Pediatr Nephrol 5(3):171\u2013174","journal-title":"Int J Pediatr Nephrol"},{"issue":"4","key":"1656_CR15","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.eururo.2004.03.023","volume":"46","author":"NJ Barber","year":"2004","unstructured":"Barber NJ, Thompson PM (2004) Nephroptosis and nephropexy\u2014hung up on the past? Eur Urol 46(4):428\u2013433. doi: 10.1016\/j.eururo.2004.03.023","journal-title":"Eur Urol"},{"issue":"8005","key":"1656_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0140-6736(77)91013-3","volume":"309","author":"D Zeeuw De","year":"1977","unstructured":"De Zeeuw D, Burema J, Donker AJM, Van Der Hem GK, Mandema E (1977) Nephroptosis and hypertension. The Lancet 309(8005):213\u2013215. doi: 10.1016\/S0140-6736(77)91013-3","journal-title":"The Lancet"},{"issue":"2","key":"1656_CR17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-0038-1624893","volume":"14","author":"B Leisner","year":"1975","unstructured":"Leisner B, B\u00fcll U, Rohloff R, Hast B, Heinze HG (1975) Bilateral determination of 131-I-hippuran clearance in nephroptoses within the scope of sequential camera scintigraphy. Nuklearmedizin Archiv 14(2):125\u2013132","journal-title":"Nuklearmedizin Archiv"},{"issue":"4","key":"1656_CR18","first-page":"268","volume":"47","author":"VT Andriole","year":"1974","unstructured":"Andriole VT, Bonadio M, Bianchi C (1974) The influence of postural changes on the glomerular filtration rate in nephroptosis. Yale J Biol Med 47(4):268\u2013276","journal-title":"Yale J Biol Med"},{"issue":"1","key":"1656_CR19","first-page":"111","volume":"27","author":"AR Fritzberg","year":"1986","unstructured":"Fritzberg AR, Kasina S, Eshima D, Johnson DL (1986) Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement. J Nucl Med 27(1):111\u2013116","journal-title":"J Nucl Med"},{"issue":"10","key":"1656_CR20","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/BF00620476","volume":"12","author":"A Taylor Jr","year":"1987","unstructured":"Taylor A Jr, Eshima D, Alazraki N (1987) 99mTc-MAG3, a new renal imaging agent: preliminary results in patients. Eur J Nucl Med 12(10):510\u2013514","journal-title":"Eur J Nucl Med"},{"issue":"9\u201310","key":"1656_CR21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF00252388","volume":"14","author":"AA Al-Nahhas","year":"1988","unstructured":"Al-Nahhas AA, Jafri RA, Britton KE, Solanki K, Bomanji J, Mather S, Carroll MA, Al-Janabi M, Frusciante V, Ajdinowic B et al (1988) Clinical experience with 99mTc-MAG3, mercaptoacetyltriglycine, and a comparison with 99mTc-DTPA. Eur J Nucl Med 14(9\u201310):453\u2013462","journal-title":"Eur J Nucl Med"},{"issue":"7","key":"1656_CR22","first-page":"1297","volume":"39","author":"AT Taylor Jr","year":"1998","unstructured":"Taylor AT Jr, Fletcher JW, Nally JV Jr, Blaufox MD, Dubovsky EV, Fine EJ, Kahn D, Morton KA, Russell CD, Sfakianakis GN, Aurell M, Dondi M, Fommei E, Geyskes G, Granerus G, Oei HY (1998) Procedure guideline for diagnosis of renovascular hypertension. Society of Nuclear Medicine. J Nucl Med 39(7):1297\u20131302","journal-title":"J Nucl Med"},{"issue":"21","key":"1656_CR23","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1093\/eurheartj\/ehp298","volume":"30","author":"A Moya","year":"2009","unstructured":"Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, Deharo JC, Gajek J, Gjesdal K, Krahn A, Massin M, Pepi M, Pezawas T, Ruiz Granell R, Sarasin F, Ungar A, van Dijk JG, Walma EP, Wieling W (2009) Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 30(21):2631\u20132671. doi: 10.1093\/eurheartj\/ehp298","journal-title":"Eur Heart J"},{"issue":"1","key":"1656_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0735-1097(02)01923-X","volume":"40","author":"K Kario","year":"2002","unstructured":"Kario K, Eguchi K, Hoshide S, Hoshide Y, Umeda Y, Mitsuhashi T, Shimada K (2002) U-curve relationship between orthostatic blood pressure change and silent cerebrovascular disease in elderly hypertensives: orthostatic hypertension as a new cardiovascular risk factor. J Am Coll Cardiol 40(1):133\u2013141. doi: 10.1016\/S0735-1097(02)01923-X","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1656_CR25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1291\/hypres.27.235","volume":"27","author":"K Eguchi","year":"2004","unstructured":"Eguchi K, Kario K, Hoshide S, Hoshide Y, Ishikawa J, Morinari M, Hashimoto T, Shimada K (2004) Greater change of orthostatic blood pressure is related to silent cerebral infarct and cardiac overload in hypertensive subjects. Hypertens Res 27(4):235\u2013241","journal-title":"Hypertens Res"},{"issue":"4","key":"1656_CR26","first-page":"343","volume":"19","author":"JH Clorius","year":"1978","unstructured":"Clorius JH, Kjelle-Schweigler M, Ostertag H, M\u00f6hring K (1978) [131I] Hippuran renography in the detection of orthostatic hypertension. J Nucl Med 19(4):343\u2013347","journal-title":"J Nucl Med"},{"issue":"6","key":"1656_CR27","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.eururo.2003.12.011","volume":"45","author":"DM Strohmeyer","year":"2004","unstructured":"Strohmeyer DM, Peschel R, Effert P, Borchert O, Janetschek G, Bartsch G, Frauscher F (2004) Changes of renal blood flow in nephroptosis: assessment by color doppler imaging, isotope renography and correlation with clinical outcome after laparoscopic nephropexy. Eur Urol 45(6):790\u2013793. doi: 10.1016\/j.eururo.2003.12.011","journal-title":"Eur Urol"},{"issue":"6","key":"1656_CR28","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3109\/08860229609047718","volume":"18","author":"L Cristol","year":"1996","unstructured":"Cristol L, Walker B, Henrich WL (1996) Distal vessel atherosclerosis as a cause for false-positive renal scintigraphy. Ren Fail 18(6):923\u2013930","journal-title":"Ren Fail"},{"issue":"5","key":"1656_CR29","doi-asserted-by":"publisher","first-page":"786","DOI":"10.2967\/jnumed.113.133454","volume":"55","author":"AT Taylor","year":"2014","unstructured":"Taylor AT (2014) Radionuclides in nephrourology, part 2: pitfalls and diagnostic applications. J Nucl Med 55(5):786\u2013798. doi: 10.2967\/jnumed.113.133454","journal-title":"J Nucl Med"},{"issue":"5","key":"1656_CR30","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.nucmedbio.2013.03.006","volume":"40","author":"N Takahara","year":"2013","unstructured":"Takahara N, Saga T, Inubushi M, Kusuhara H, Seki C, Ito S, Oyama N, Yokoyama O, Sugiyama Y, Fujibayashi Y (2013) Drugs interacting with organic anion transporter-1 affect uptake of Tc-99m-mercaptoacetyl-triglycine (MAG3) in the human kidney: therapeutic drug interaction in Tc-99m-MAG3 diagnosis of renal function and possible application of Tc-99m-MAG3 for drug development. Nucl Med Biol 40(5):643\u2013650. doi: 10.1016\/j.nucmedbio.2013.03.006","journal-title":"Nucl Med Biol"},{"issue":"3","key":"1656_CR31","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s11095-006-9181-4","volume":"24","author":"AN Rizwan","year":"2007","unstructured":"Rizwan AN, Burckhardt G (2007) Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles. Pharm Res 24(3):450\u2013470. doi: 10.1007\/s11095-006-9181-4","journal-title":"Pharm Res"},{"issue":"11","key":"1656_CR32","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1021\/mp300365t","volume":"9","author":"P Duan","year":"2012","unstructured":"Duan P, Li S, Ai N, Hu L, Welsh WJ, You G (2012) Potent inhibitors of human organic anion transporters 1 and 3 from clinical drug libraries: discovery and molecular characterization. Mol Pharm 9(11):3340\u20133346. doi: 10.1021\/mp300365t","journal-title":"Mol Pharm"},{"issue":"1","key":"1656_CR33","first-page":"80","volume":"45","author":"N Shikano","year":"2004","unstructured":"Shikano N, Kanai Y, Kawai K, Ishikawa N, Endou H (2004) Transport of 99mTc-MAG3 via rat renal organic anion transporter 1. J Nucl Med 45(1):80\u201385","journal-title":"J Nucl Med"},{"issue":"3","key":"1656_CR34","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2125.2006.02655.x","volume":"62","author":"SV Vormfelde","year":"2006","unstructured":"Vormfelde SV, Schirmer M, Hagos Y, Toliat MR, Engelhardt S, Meineke I, Burckhardt G, Nurnberg P, Brockmoller J (2006) Torsemide renal clearance and genetic variation in luminal and basolateral organic anion transporters. Br J Clin Pharmacol 62(3):323\u2013335. doi: 10.1111\/j.1365-2125.2006.02655.x","journal-title":"Br J Clin Pharmacol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-017-1656-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-017-1656-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-017-1656-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,29]],"date-time":"2019-09-29T07:29:32Z","timestamp":1569742172000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-017-1656-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,11]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["1656"],"URL":"https:\/\/doi.org\/10.1007\/s11255-017-1656-1","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,11]]}}}